Skip to main content

Table 3 Diagnostic performance of biomarkers for diagnosis of severe sepsis and septic shock at days 1, 3 and 8 of ICU treatment, analyzed as area under the curve (95% CI)

From: Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment

 

Presepsin

Interleukin-6

Procalcitonin

C-reactive protein

White blood cells

Day 1

  

Septic shock (n = 74)

0.80 (0.73, 0.86)

0.86 (0.80, 0.91)

0.83 (0.77, 0.90)

0.62 (0.49, 0.74)

0.53 (0.41, 0.62)

P?= 0.0001

P = 0.0001

P = 0.0001

P = 0.06

P = 0.7

Day 1: Controls n = 60; SIRS n = 9; sepsis n = 5; severe sepsis n = 28; septic shock n = 74

Day 3

     

≥ Sepsis (n = 81)

0.84 (0.72, 0.96)

0.81 (0.70, 0.92)

0.69 (0.52, 0.87)

0.69 (0.54, 0.83)

0.73 (0.60, 0.87)

P = 0.0001

P = 0.001

P = 0.03

P = 0.04

P = 0.009

≥ Severe sepsis (n = 67)

0.80 (0.70, 0.91)

0.71 (0.60, 0.81)

0.66 (0.52, 0.80)

0.61 (0.49, 0.74)

0.59 (0.47, 0.72)

P = 0.0001

P = 0.003

P = 0.02

P = 0.1

P = 0.2

Septic shock (n = 39)

0.72 (0.61, 0.82)

0.76 (0.66, 0.87)

0.66 (0.55, 0.77)

0.72 (0.62, 0.83)

0.57 (0.45, 0.70)

P = 0.0001

P = 0.0001

P = 0.01

P = 0.0001

P = 0.3

Day 3: SIRS n = 15; sepsis n = 14; severe sepsis n = 28; septic shock n = 39

Day 8

  

≥ Sepsis (n = 48)

0.82 (0.71, 0.93)

0.74 (0.61, 0.87)

0.64 (0.50, 0.78)

0.69 (0.54, 0.84)

0.75 (0.64, 0.87)

P = 0.0001

P = 0.001

P = 0.06

P = 0.01

P = 0.001

≥ Severe sepsis (n = 37)

0.77 (0.65, 0.88)

0.73 (0.61, 0.85)

0.68 (0.55, 0.81)

0.65 (0.51, 0.78)

0.71 (0.58, 0.83)

P = 0.0001

P = 0.001

P = 0.01

P = 0.04

P = 0.004

Septic shock (n = 18)

0.79 (0.66, 0.92)

0.69 (0.55, 0.83)

0.78 (0.65, 0.92)

0.67 (0.53, 0.81)

0.68 (0.53, 0.84)

P = 0.0001

P = 0.02

P = 0.001

P = 0.04

P = 0.02

Day 8: SIRS n = 28; sepsis n = 11; severe sepsis n = 19; septic shock n = 18

  1. A minimal area under the curve was set at ≥0.75 (highlighted in bold type). SIRS, systemic inflammatory response syndrome.